ZYLOXTB Releases Updated Board and Committee Structure

Bulletin Express05-13

Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) announced the composition of its Board of Directors and the three standing committees as of 13 May 2026.

The nine-member Board is led by Executive Chairman Dr. Jonathon Zhong Zhao. Other executive directors include Mr. Yang Xie (employee director) and Dr. Zheng Li. Non-executive directors are Dr. Steven Dasong Wang and Mr. Dongfang Li. Independent non-executive directors comprise Dr. Jian Ji, Ms. Yun Qiu and Dr. Xiang Qian.

Committee assignments are as follows:

• Audit Committee: Chaired by Ms. Yun Qiu with Dr. Jian Ji and Dr. Xiang Qian as members. • Remuneration Committee: Chaired by Dr. Jian Ji; members include Mr. Dongfang Li and Dr. Xiang Qian. • Nomination Committee: Chaired by Dr. Jonathon Zhong Zhao; members are Dr. Jian Ji and Ms. Yun Qiu.

The disclosure provides investors with clarity on Zylox-Tonbridge’s governance framework, highlighting a balanced mix of executive, non-executive and independent oversight across key board committees.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment